Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

The quantitatively analysis of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) and its correlation with response rate of EGFR tyrosine kinase inhibitors (TKI)

10.1158/diag-10-pr10 ◽

2010 ◽

Cited By ~ 1

Author(s):

Jun Li ◽

Zhao Chen ◽

Daqiang Sun ◽

Meilin Xu ◽

Xun Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Response Rate ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations

Lung Cancer ◽

10.1016/j.lungcan.2015.01.004 ◽

2015 ◽

Vol 87 (3) ◽

pp. 311-317 ◽

Cited By ~ 31

Author(s):

Chang Dong Yeo ◽

Ki Hoon Park ◽

Chan Kwon Park ◽

Sang Haak Lee ◽

Seung Joon Kim ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Annals of Oncology ◽

10.1093/annonc/mdw332.20 ◽

2016 ◽

Vol 27 ◽

pp. iv9

Author(s):

M. Bonomi ◽

L. Bonomi ◽

M.G. Sauta ◽

A.C. Bettini ◽

M. Squadroni ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3464-9 ◽

2017 ◽

Vol 80 (6) ◽

pp. 1179-1187 ◽

Cited By ~ 7

Author(s):

Kaiyan Chen ◽

Xiaoqing Yu ◽

Haiyang Wang ◽

Zhiyu Huang ◽

Yanjun Xu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

Tumor Biology ◽

10.1007/s13277-015-3893-1 ◽

2015 ◽

Vol 37 (1) ◽

pp. 1061-1069 ◽

Cited By ~ 11

Author(s):

Xiaoqing Zhang ◽

Junwei Fan ◽

Yuping Li ◽

Shengtao Lin ◽

Ping Shu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore

Annals of Oncology ◽

10.1093/annonc/mdy425.033 ◽

2018 ◽

Vol 29 ◽

pp. ix161 ◽

Cited By ~ 1

Author(s):

B. Chua ◽

E.H. Tan ◽

D.W.-T. Lim ◽

M.-K. Ang ◽

D.S.W. Tan ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Real World Data ◽

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib

Seminars in Oncology ◽

10.1053/j.seminoncol.2019.08.004 ◽

2019 ◽

Vol 46 (3) ◽

pp. 271-283 ◽

Cited By ~ 19

Author(s):

Ashiq Masood ◽

Rama Krishna Kancha ◽

Janakiraman Subramanian

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

Annals of Oncology ◽

10.1093/annonc/mdx426.006 ◽

2017 ◽

Vol 28 ◽

pp. vi56

Author(s):

I. Stasi ◽

A. Farnesi ◽

E. Vasile ◽

I. Petrini ◽

M. Luccchesi ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis

Thyroid dysfunction in non-small cell lung cancer patients treated with epidermal growth factor receptor and anaplastic lymphoma kinase inhibitors: Results of a prospective cohort

Lung Cancer ◽

10.1016/j.lungcan.2020.11.007 ◽

2021 ◽

Vol 151 ◽

pp. 16-19

Author(s):

Swati Soni ◽

Ashu Rastogi ◽

Kuruswamy T. Prasad ◽

Digambar Behera ◽

Navneet Singh

Keyword(s):

Lung Cancer ◽

Thyroid Dysfunction ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Anaplastic Lymphoma ◽

Clinical Significance of Disease Flares in Patients with Non-small Cell Lung Cancer with Positive EGFR Mutations Following the Suspension of Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Haigan ◽

10.2482/haigan.54.1 ◽

2014 ◽

Vol 54 (1) ◽

pp. 1-5 ◽

Cited By ~ 1

Author(s):

Ai Yamamoto ◽

Kazutoshi Isobe ◽

Kyohei Kaburaki ◽

Arisa Kinoshita ◽

Tomohiro Wada ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase Inhibitors

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽